A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Sep, 4 2023
Dec, 4 2025
Mar, 30 2026
Dec, 21 2025
Jan, 13 2026